Charter Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Charter Capital Management's ABBV Position: Q3 2026 in Review
Charter Capital Management increased its AbbVie (ABBV) stake by 0.1% in Q3 2026, buying an estimated $256 and bringing the position to 987 shares worth $258K. The position accounts for 0.12% of the portfolio, ranked #60.
Charter Capital Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Charter Capital Management held 987 shares of AbbVie worth $258K as of Q3 2026.
- Charter Capital Management bought 1 AbbVie share in Q3 2026, an estimated $256.
- AbbVie made up 0.12% of Charter Capital Management's portfolio in Q3 2026, its #60 holding.
- Charter Capital Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Charter Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.